BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24121018)

  • 1. Human insulin does not increase prostate cancer risk in Taiwanese.
    Tseng CH
    Clin Genitourin Cancer; 2014 Feb; 12(1):e7-12. PubMed ID: 24121018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human insulin does not increase bladder cancer risk.
    Tseng CH
    PLoS One; 2014; 9(1):e86517. PubMed ID: 24466131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Eur J Clin Invest; 2014 Aug; 44(8):736-42. PubMed ID: 24931333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan.
    Tseng CH
    Gynecol Oncol; 2013 Oct; 131(1):135-9. PubMed ID: 23877016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone is not associated with an increased risk of bladder cancer.
    Tseng CH
    Cancer Epidemiol; 2013 Aug; 37(4):385-9. PubMed ID: 23619142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Ann Med; 2013 Dec; 45(8):539-44. PubMed ID: 24215589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
    Tseng CH
    BMC Cancer; 2013 Jan; 13():7. PubMed ID: 23286275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
    Tseng CH
    Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
    Tseng CH
    BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese.
    Tseng CH
    BMC Cancer; 2015 Feb; 15():41. PubMed ID: 25655946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Insulin Therapy Is Associated With an Increased Risk of Lung Cancer: A Population-Based Retrospective Cohort Study.
    Tseng CH
    Front Endocrinol (Lausanne); 2019; 10():443. PubMed ID: 31354621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.